Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.41
-0.05 (-0.36%)
Jan 23, 2025, 12:18 PM EST - Market open
Avid Bioservices Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 | 2019 - 2015 |
| Revenue | 150.45 | 139.91 | 149.27 | 119.6 | 95.87 | 59.7 | Upgrade
|
| Revenue Growth (YoY) | 6.75% | -6.27% | 24.81% | 24.75% | 60.58% | 11.38% | Upgrade
|
| Cost of Revenue | 138.89 | 132.59 | 117.79 | 82.95 | 66.56 | 55.77 | Upgrade
|
| Gross Profit | 11.55 | 7.32 | 31.48 | 36.65 | 29.31 | 3.93 | Upgrade
|
| Selling, General & Admin | 31.93 | 26 | 27.78 | 21.23 | 17.06 | 14.52 | Upgrade
|
| Operating Expenses | 31.93 | 26 | 27.78 | 21.23 | 17.06 | 14.52 | Upgrade
|
| Operating Income | -20.38 | -18.68 | 3.7 | 15.42 | 12.24 | -10.59 | Upgrade
|
| Interest Expense | -8.86 | -4.34 | -3.01 | -2.68 | -1.16 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.81 | -1.79 | 1.14 | 0.3 | 0.13 | 0.48 | Upgrade
|
| EBT Excluding Unusual Items | -34.05 | -24.8 | 1.83 | 13.04 | 11.21 | -10.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.18 | -0.23 | -0.14 | -0.38 | - | - | Upgrade
|
| Asset Writedown | - | - | -0.1 | - | - | - | Upgrade
|
| Other Unusual Items | -1.9 | -1.9 | - | - | - | -0.36 | Upgrade
|
| Pretax Income | -35.23 | -26.93 | 1.59 | 12.66 | 11.21 | -10.47 | Upgrade
|
| Income Tax Expense | 116.82 | 113.83 | 1.33 | -115.01 | - | - | Upgrade
|
| Earnings From Continuing Operations | -152.05 | -140.75 | 0.26 | 127.67 | 11.21 | -10.47 | Upgrade
|
| Net Income | -152.05 | -140.75 | 0.26 | 127.67 | 11.21 | -10.47 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 7.89 | 4.69 | Upgrade
|
| Net Income to Common | -152.05 | -140.75 | 0.26 | 127.67 | 3.32 | -15.15 | Upgrade
|
| Net Income Growth | - | - | -99.80% | 1038.71% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 64 | 63 | 62 | 61 | 58 | 56 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 63 | 64 | 70 | 59 | 56 | Upgrade
|
| Shares Change (YoY) | 1.33% | -0.91% | -9.50% | 18.59% | 5.50% | 0.62% | Upgrade
|
| EPS (Basic) | -2.39 | -2.23 | 0.00 | 2.08 | 0.06 | -0.27 | Upgrade
|
| EPS (Diluted) | -2.39 | -2.23 | 0.00 | 1.84 | 0.06 | -0.27 | Upgrade
|
| EPS Growth | - | - | -99.78% | 3127.60% | - | - | Upgrade
|
| Free Cash Flow | -9.68 | -20.85 | -90.53 | -46.95 | 21.32 | 2.02 | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.33 | -1.42 | -0.67 | 0.36 | 0.04 | Upgrade
|
| Gross Margin | 7.68% | 5.23% | 21.09% | 30.64% | 30.57% | 6.59% | Upgrade
|
| Operating Margin | -13.55% | -13.35% | 2.48% | 12.89% | 12.77% | -17.73% | Upgrade
|
| Profit Margin | -101.07% | -100.60% | 0.17% | 106.75% | 3.46% | -25.38% | Upgrade
|
| Free Cash Flow Margin | -6.43% | -14.90% | -60.65% | -39.25% | 22.24% | 3.38% | Upgrade
|
| EBITDA | -7.91 | -7.57 | 10.91 | 19.9 | 15.7 | -7.49 | Upgrade
|
| EBITDA Margin | -5.26% | -5.41% | 7.31% | 16.64% | 16.37% | -12.55% | Upgrade
|
| D&A For EBITDA | 12.47 | 11.11 | 7.21 | 4.48 | 3.45 | 3.09 | Upgrade
|
| EBIT | -20.38 | -18.68 | 3.7 | 15.42 | 12.24 | -10.59 | Upgrade
|
| EBIT Margin | -13.55% | -13.35% | 2.48% | 12.89% | 12.77% | -17.73% | Upgrade
|
| Effective Tax Rate | - | - | 83.71% | - | - | - | Upgrade
|
| Advertising Expenses | - | 0.8 | 0.7 | 0.6 | 0.3 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.